| Статус: | Unknown status |
| Фаза: | Phase 3 |
| Начало: | 7 сентября 2020 г. |
| Окончание: | 1 мая 2021 г. |
| Описание: | Randomized, double-blind (blinded for the trial subject and the study physician), placebo controlled, multi-center clinical trial in parallel assignment of efficacy, immunogenicity, and safety of the Gam-COVID-Vac combined vector vaccine against the SARS-CoV-2-induced coronavirus infection in adults in the SARS-СoV-2 infection prophylactic treatment. |
| смотреть на ClinicalTrials.gov |
| Статус: | Completed |
| Фаза: | Phase 1 |
| Начало: | 21 января 2019 г. |
| Окончание: | 18 мая 2020 г. |
| Описание: | To evaluate safety and tolerability of VM-1500A-LAI after its single and multiple intramuscular ascending dose to healthy volunteers |
| смотреть на ClinicalTrials.gov |
| Статус: | Completed |
| Фаза: | Phase 1 |
| Начало: | 18 декабря 2018 г. |
| Окончание: | 2 апреля 2019 г. |
| Описание: | A randomized once weekly dose for 8 weeks, study in Healthy HIV-Uninfected Volunteers. Each of 3 parallel groups (40 mg, 80 mg and 160mg) enrolls 12 subjects. |
| смотреть на ClinicalTrials.gov |
| Статус: | Completed |
| Фаза: | Phase 1 |
| Начало: | 14 ноября 2018 г. |
| Окончание: | 6 сентября 2019 г. |
| Описание: | The study assesses PK and safety of other drugs, such as some antibiotics, proton pump inhibitors, statins, and combined oral contraceptives when co-administered with Elpida® |
| смотреть на ClinicalTrials.gov |